Harold Koendgen

Statistics

Publications

Citations

2.1K

H-Index

Active since

2017

Affiliations

University Hospital of Basel(Current)

Roche (Switzerland)

University of California, San Francisco

University of Basel

The University of Texas Health Science Center at Houston

Harold Koendgen is an author at University Hospital of Basel specializing in multiple sclerosis pharmacotherapy, multiple sclerosis therapy, and neurology.

ORCID

Publications per year

2017–2023

Publications

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

Ludwig Kappos, Jerry S. Wolinsky, Gavin Giovannoni et al. · JAMA Neurology · 2020 · 622 citations · Full text

Medicine, Neurology, Disability Management +15

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies

Pei‐Ran Ho, Harold Koendgen, Nolan Campbell et al. · The Lancet Neurology · 2017 · 322 citations

Life Sciences, Neurology, Neuroscience +14

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

Stephen L. Hauser, Ludwig Kappos, Xavier Montalbán et al. · Neurology · 2021 · 177 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Epidemiology +15

Five years of ocrelizumab in relapsing multiple sclerosis

Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold et al. · Neurology · 2020 · 158 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

Ludwig Kappos, Helmut Butzkueven, Heinz Wiendl et al. · Multiple Sclerosis Journal · 2017 · 150 citations · Full text

Medicine, Neurology, Disability Management +16

1–5 of 20